ACM
CERE

AlphaCrest Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

AlphaCrest Capital Management’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,328
Closed -$335K – 1445
2021
Q4 		$335K Buy
+10,328
New +$335K 0.01% 1233